The latest announcement revealed that 15 stocks are expected to erupt
Yibai Pharmaceutical plans to invest 600 million yuan to build a new plant in Mei'an Technology New City to expand anti-tumor drug production. Yibai Pharmaceuticals
| Time: January 9, 2020 08:42:40 China Finance |
announced that the company's wholly-owned subsidiary Changan Pharmaceutical's existing production capacity can no longer meet the company's exclusive original research and development of new drugs, Growing market demand for third-generation platinum-based antitumor drugs for injection of loplatin. In order to solve the bottleneck of development and to increase the company's production capacity of chemical drugs including anti-tumor drugs, Chang'an Pharmaceutical intends to invest in the construction of the "Meian Technology New City New Plant Construction Project" in Mei'an Science and Technology New City, Haikou. This project After completion, it will be engaged in the production and operation of related products. The total investment in fixed assets of this project is expected to be 603 million yuan.